The changing trends of the main differential metabolites in the WKY, SHR and Model groups. by Xiao Zhang (152326)

Subjects:

Relative monthly changes in calculated GM/h on typical cattle TAHs in Slovenia and scatter box plot for GM/h. by Jure Brečko (20314959)

Subjects:

(A) FC and VIP bubble chart of Model.vs.WKY comparison group; (B) Hierarchical clustering results of differential metabolites in Model.vs.WKY comparison group (only the top 50 VIP... by Xiao Zhang (152326)

Subjects:

(A) Escape latency; (B) Average swimming speed; (C) The number of platform crossings; (D) The time spent searching for the target quadrant; (E) The total distance traveled by the t... by Xiao Zhang (152326)

Subjects:

NS suppresses inflammation induced by Ox-LDL in RAW264.7 cells. by Yihua Wang (491766)

Subjects:

The primer sequence used in this study. by Yu Zhang (12946)

“…In local samples, KIRC tissues exhibited increased infiltration of NFKB2+ cells and decreased levels of ACADM+ and ANGPTL4+ cells (all <i><i>P</i></i> < 0.05). …”

The tumor volume (mm³) of the mice in each group. by Yu Zhang (12946)

“…In local samples, KIRC tissues exhibited increased infiltration of NFKB2+ cells and decreased levels of ACADM+ and ANGPTL4+ cells (all <i><i>P</i></i> < 0.05). …”

IFA disarmed capsule-mediated immune evasion. by Tingting Wang (123983)

IFA reduced the capsular biosynthesis through altering bacterial metabolism. by Tingting Wang (123983)

Raw data. by Yin Jie (21464235)

“…In conclusion, this study revealed that 1’,4’-<i>trans</i>-diol-ABA may perform a significant function in increasing crop salt-stress tolerance.…”

Neutralization with additional bevacizumab to serum samples pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

“…<b>c</b> Further addition of bevacizumab to serum samples post-bevacizumab administration significantly decreased VEGF-A121 levels in samples to which 20 and 200 μg/mL bevacizumab was added (ANOVA: <i>p</i> < 0.0001; Dunnett’s multiple comparisons test: +2 μg/mL, <i>p</i> = 0.7096 vs control; +20 μg/mL, <i>p</i> = 0.0107 vs control; +200 μg/mL, <i>p</i> < 0.0001 vs control). …”

<b> </b> Spatial memory assessment in Morris water maze test. 5A: Effect of different treatments on time spent in the target zone. Alcl3 significantly decreased the time spent in the target zone with respect to the saline-treated group (p < 0.01).... by Atefeh Sadeghi (21253051)

“…<p><b> </b> Spatial memory assessment in Morris water maze test. 5A: Effect of different treatments on time spent in the target zone. Alcl3 significantly decreased the time spent in the target zone with respect to the saline-treated group (p < 0.01). …”

Blood concentrations of VEGF-A121, VEGF-A165, and VEGF-A pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

Effect of the VEGF-A–bevacizumab complex removal using immunoprecipitation on the concentrations of VEGF-A121, VEGF-A165, and VEGF-A. by Masashi Okawa (8951294)

VEGF-A121, VEGF-A165, and VEGF-A contents per unit platelets. by Masashi Okawa (8951294)

Characterization of systolic pulmonary arterial pressure (sPAP) of WT BMP9 in rats. by Tobias G. Schips (21799838)

Subjects:

Estimated average absolute and relative changes in energy (kcal/capita/day) from the no-policy counterfactual by phase, high-in status, and SES. by Lindsey Smith Taillie (3159258)

Subjects:

Estimated average absolute and relative changes in energy (kcal/capita/day) from the no-policy counterfactual by phase and number of excess nutrients of concern. by Lindsey Smith Taillie (3159258)

Subjects:

Summary of cell-based assay EC50 results for WT BMP9 and A347E variant. by Tobias G. Schips (21799838)

Subjects:

Weighted sociodemographic characteristics of the Kantar WorldPanel sample by year. by Lindsey Smith Taillie (3159258)

Subjects: